Atrium and paroxetine-related severe hepatitis

J Clin Gastroenterol. 1999 Jan;28(1):52-5. doi: 10.1097/00004836-199901000-00014.

Abstract

Two cases of severe hepatitis in young women using Atrium and paroxetine are presented. Both patients presented jaundice, marked increase in aminotransferases activities, and pronounced prolongation in prothrombin time. In both cases, liver biopsy specimen examination revealed lesions compatible with drug-related injury. Other causes of hepatic injury were reasonably ruled out by complete careful screening. Outcome was marked by rapid complete recovery in one case and by slow recovery in the other. We suggest that simultaneous treatment with Atrium and paroxetine could increase each of these drugs' hepatotoxicity.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Anxiety Agents / administration & dosage
  • Anti-Anxiety Agents / adverse effects*
  • Barbiturates / administration & dosage
  • Barbiturates / adverse effects*
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / pathology
  • Drug Combinations
  • Drug Interactions
  • Female
  • Humans
  • Liver / pathology
  • Paroxetine / administration & dosage
  • Paroxetine / adverse effects*
  • Phenobarbital / administration & dosage
  • Phenobarbital / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / adverse effects*

Substances

  • Anti-Anxiety Agents
  • Barbiturates
  • Drug Combinations
  • Serotonin Uptake Inhibitors
  • Paroxetine
  • difebarbamate, febarbamate, phenobarbital drug combination
  • Phenobarbital